399 related articles for article (PubMed ID: 11169766)
1. Diminished levels of the putative tumor suppressor proteins EXT1 and EXT2 in exostosis chondrocytes.
Bernard MA; Hall CE; Hogue DA; Cole WG; Scott A; Snuggs MB; Clines GA; Lüdecke HJ; Lovett M; Van Winkle WB; Hecht JT
Cell Motil Cytoskeleton; 2001 Feb; 48(2):149-62. PubMed ID: 11169766
[TBL] [Abstract][Full Text] [Related]
2. Cytoskeletal abnormalities in chondrocytes with EXT1 and EXT2 mutations.
Bernard MA; Hogue DA; Cole WG; Sanford T; Snuggs MB; Montufar-Solis D; Duke PJ; Carson DD; Scott A; Van Winkle WB; Hecht JT
J Bone Miner Res; 2000 Mar; 15(3):442-50. PubMed ID: 10750558
[TBL] [Abstract][Full Text] [Related]
3. Reevaluation of a genetic model for the development of exostosis in hereditary multiple exostosis.
Hall CR; Cole WG; Haynes R; Hecht JT
Am J Med Genet; 2002 Sep; 112(1):1-5. PubMed ID: 12239711
[TBL] [Abstract][Full Text] [Related]
4. EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis.
Stickens D; Brown D; Evans GA
Dev Dyn; 2000 Jul; 218(3):452-64. PubMed ID: 10878610
[TBL] [Abstract][Full Text] [Related]
5. Differentiation-induced loss of heparan sulfate in human exostosis derived chondrocytes.
Hecht JT; Hayes E; Haynes R; Cole WG; Long RJ; Farach-Carson MC; Carson DD
Differentiation; 2005 Jun; 73(5):212-21. PubMed ID: 16026543
[TBL] [Abstract][Full Text] [Related]
6. Germline mutations in the EXT1 and EXT2 genes in Korean patients with hereditary multiple exostoses.
Park KJ; Shin KH; Ku JL; Cho TJ; Lee SH; Choi IH; Phillipe C; Monaco AP; Porter DE; Park JG
J Hum Genet; 1999; 44(4):230-4. PubMed ID: 10429361
[TBL] [Abstract][Full Text] [Related]
7. Association of EXT1 and EXT2, hereditary multiple exostoses gene products, in Golgi apparatus.
Kobayashi S; Morimoto K; Shimizu T; Takahashi M; Kurosawa H; Shirasawa T
Biochem Biophys Res Commun; 2000 Feb; 268(3):860-7. PubMed ID: 10679296
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes.
Wuyts W; Van Hul W
Hum Mutat; 2000; 15(3):220-7. PubMed ID: 10679937
[TBL] [Abstract][Full Text] [Related]
9. [From gene to disease; hereditary multiple exostoses].
Wuyts W; Bovée JV; Hogendoorn PC
Ned Tijdschr Geneeskd; 2002 Jan; 146(4):162-4. PubMed ID: 11845565
[TBL] [Abstract][Full Text] [Related]
10. 20 novel point mutations and one large deletion in EXT1 and EXT2 genes: report of diagnostic screening in a large Italian cohort of patients affected by hereditary multiple exostosis.
Ciavarella M; Coco M; Baorda F; Stanziale P; Chetta M; Bisceglia L; Palumbo P; Bengala M; Raiteri P; Silengo M; Caldarini C; Facchini R; Lala R; Cavaliere ML; De Brasi D; Pasini B; Zelante L; Guarnieri V; D'Agruma L
Gene; 2013 Feb; 515(2):339-48. PubMed ID: 23262345
[TBL] [Abstract][Full Text] [Related]
11. The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes.
Stickens D; Clines G; Burbee D; Ramos P; Thomas S; Hogue D; Hecht JT; Lovett M; Evans GA
Nat Genet; 1996 Sep; 14(1):25-32. PubMed ID: 8782816
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of locus heterogeneity and EXT1 mutations in 34 families with hereditary multiple exostoses.
Raskind WH; Conrad EU; Matsushita M; Wijsman EM; Wells DE; Chapman N; Sandell LJ; Wagner M; Houck J
Hum Mutat; 1998; 11(3):231-9. PubMed ID: 9521425
[TBL] [Abstract][Full Text] [Related]
13. A novel deletion mutation of the EXT2 gene in a large Chinese pedigree with hereditary multiple exostosis.
Xiao CY; Wang J; Zhang SZ; Van Hul W; Wuyts W; Qiu WM; Wu H; Zhang G
Br J Cancer; 2001 Jul; 85(2):176-81. PubMed ID: 11461073
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the EXT1 and EXT2 genes in hereditary multiple exostoses.
Wuyts W; Van Hul W; De Boulle K; Hendrickx J; Bakker E; Vanhoenacker F; Mollica F; Lüdecke HJ; Sayli BS; Pazzaglia UE; Mortier G; Hamel B; Conrad EU; Matsushita M; Raskind WH; Willems PJ
Am J Hum Genet; 1998 Feb; 62(2):346-54. PubMed ID: 9463333
[TBL] [Abstract][Full Text] [Related]
15. An optimized DHPLC protocol for molecular testing of the EXT1 and EXT2 genes in hereditary multiple osteochondromas.
Wuyts W; Radersma R; Storm K; Vits L
Clin Genet; 2005 Dec; 68(6):542-7. PubMed ID: 16283885
[TBL] [Abstract][Full Text] [Related]
16. Association of autism in two patients with hereditary multiple exostoses caused by novel deletion mutations of EXT1.
Li H; Yamagata T; Mori M; Momoi MY
J Hum Genet; 2002; 47(5):262-5. PubMed ID: 12032595
[TBL] [Abstract][Full Text] [Related]
17. Novel EXT1 and EXT2 mutations identified by DHPLC in Italian patients with multiple osteochondromas.
Pedrini E; De Luca A; Valente EM; Maini V; Capponcelli S; Mordenti M; Mingarelli R; Sangiorgi L; Dallapiccola B
Hum Mutat; 2005 Sep; 26(3):280. PubMed ID: 16088908
[TBL] [Abstract][Full Text] [Related]
18. Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas.
Hameetman L; David G; Yavas A; White SJ; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
J Pathol; 2007 Mar; 211(4):399-409. PubMed ID: 17226760
[TBL] [Abstract][Full Text] [Related]
19. [EXT1 and EXT2 mutation identified by denaturing high performance liquid chromatograph in three families with hereditary multiple exostoses].
Zhang M; Liu SG; Li FF; Zhou WH; Jin XH; Ma X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):646-51. PubMed ID: 18067075
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the anatomic burden of patients with hereditary multiple exostoses.
Alvarez CM; De Vera MA; Heslip TR; Casey B
Clin Orthop Relat Res; 2007 Sep; 462():73-9. PubMed ID: 17589361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
